Laser surgery for drug-resistant epilepsy
Part of Brain & nervous system clinical trials.
This trial tests a new, less invasive surgery called MRI-guided laser ablation (MRgLITT) for people with drug-resistant mesial temporal lobe epilepsy. It aims to stop or reduce seizures by using a laser to destroy the tiny area of the brain causing them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have drug-resistant mesial temporal lobe epilepsy (meaning seizures that start in a specific area of the brain and don't respond to medication).
- You have at least one seizure per month.
- You have not had brain surgery before.
- You do not have any other growths or lesions in your brain (like tumors or cysts).
- You do not have serious health problems that would make surgery risky (like severe heart disease, lung problems, or an uncontrolled infection).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced MRI scans to look at brain structure in people with temporal lobe epilepsy. It may help doctors better understand the condition and improve treatment.
This study tests a new, non-invasive treatment called 'temporal interference' for people whose epilepsy seizures are not controlled by medication. It aims to reduce seizures by using low-level electrical fields to calm overactive brain cells.
This early-stage trial tests whether transplanting special cells (UX-GIP001) into the brain can reduce seizures in people with drug-resistant epilepsy affecting the mesial temporal lobe—a common seizure origin that doesn't respond well to medications. The goal is to evaluate safety and whether this approach helps control seizures.
This trial looks at using brain surgery to treat epilepsy that does not improve with usual medicines, or epilepsy caused by a brain tumor. It may help some people reduce seizures if surgery is appropriate for their situation.
This trial tests a type of brain stimulation therapy (TIS) for people with temporal lobe epilepsy that hasn't responded well to seizure medications. The goal is to help reduce how often seizures happen.
This trial tests a low-intensity focused ultrasound treatment aimed at reducing seizures caused by problems in one side of the hippocampus (a brain area involved in memory and seizures). It’s for people whose seizures have not responded to several seizure medicines and who have been offered a specific type of surgery.
Hear when a new Temporal Lobe Epilepsy (TLE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.